Login

De Belegger on Tour - Pitch with Francis Van Eeckhout, CEO Deceuninck | Francis Van Eeckhout - CEO of Deceuninck 00:10:00

Share On Facebook Share On Twitter

Francis Van Eeckhout is Chairman/Interim CEO at Deceuninck.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Nuveen is a global investment leader, managing an array of public and private assets for clients around the world and on behalf of our parent company TIAA , one of the world’s largest institutional investors,1 a highly-rated2 insurance company and a retir
00:10:00
Meri Grogan: Syverson Strege Team | Meri Grogan - Director of Finance & Administration of Syverson Strege
00:10:00
"Shantanu Narayen on Creativity, Innovation, and Leadership | CEO of Adobe | In Good Company Podcast by Norges Bank Investment Management"
00:10:00
Introduction of Delta Technologies Plc. at the 2023 event of Agriculture | Kim Batcheler, CEO, Delta Technologies NyrtDELTA:BUD
00:00:00
Dr Stuart Quin, CEO of Medica Group PLC
00:10:00
Key Traits for a Successful Founding Team: Vision, Resilience, and Leadership
00:10:00
Chris Lee on Job Growth from Ports America's Investment in the Port of Oakland
00:00:00
Punit Dhillon, President & CEO of OncoSec Medical
00:10:00
Martin Migoya, Chairman and CEO of Globant, joins NYSE Floor Talk along with Mariano Gomide de Faria.
00:10:00
Fortune Minerals CEO Robin Goad Showcases $145M Vertically Integrated Critical Minerals Project Supporting Energy Transition and National Security
00:00:00
DR. BERNARD COURTIEU CHIEF EXECUTIVE OFFICER, Integragen
00:10:00
Opportunities and Challenges in the Gulf Amid Geopolitical Instability

© 2017 - Neuhu+